image
Healthcare - Medical - Diagnostics & Research - NASDAQ - CN
$ 2.32
2.48 %
$ 2.5 M
Market Cap
-0.54
P/E
CASH FLOW STATEMENT
-92.3 M OPERATING CASH FLOW
63.93%
-4.41 M INVESTING CASH FLOW
52.56%
-72 K FINANCING CASH FLOW
99.85%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Burning Rock Biotech Limited
image
00(100m)(100m)(200m)(200m)(300m)(300m)(400m)(400m)(500m)(500m)(600m)(600m)(700m)(700m)2018201820192019202020202021202120222022202320232024202420252025
Net Income -347 M
Depreciation & Amortization 52.2 M
Capital Expenditures -5.98 M
Stock-Based Compensation 156 M
Change in Working Capital -36.5 M
Others 51.9 M
Free Cash Flow -98.2 M

Cash Flow

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017
OPERATING CASH FLOW
Net Income (346.6) (653.7) (971.2) (796.7) (407.2) (169.2) (177.5) (131.3)
Depreciation & Amortization 52.2 133.4 124.1 47.8 33.3 31.4 24.7 21.3
Deferred Income Tax 0 0 0 15.4 0 15.6 1.4 1.2
Stock Based Compensation 155.6 260.7 326.8 282.4 173.2 22.8 5.1 4.1
Other Operating Activities 83.1 55.9 57.2 35.6 15.1 1.8 3.7 5.8
Change in Working Capital (36.5) (52.2) 6.3 (62.4) 112.1 (130.5) (6.2) (34.8)
Cash From Operations (92.3) (255.8) (456.8) (477.9) (73.5) (228.0) (148.8) (133.7)
INVESTING CASH FLOW
Capital Expenditures (6.0) (9.4) (62.0) (213.4) (79.5) (45.7) (24.7) (23.0)
Other Items 1.6 84 K 54.6 295.1 (29.8) (300.9) 130.8 (168.1)
Cash From Investing Activities (4.4) (9.3) (7.5) 81.7 (109.3) (346.7) 106.1 (191.1)
FINANCING CASH FLOW
Common Stock Repurchased 72 K (7.0) (71.8) (4.3) 0 (3.6) (1.5) (9.1)
Total Debt Repaid 0 0 (2.4) (44.8) (20.6) (81.6) 82.9 11.4
Dividends Paid 0 0 0 0 0 0 0 0
Other Financing Activities 0 (41.9) (12.0) (3.8) 334.4 657.0 0.5 351.8
Cash From Financing Activities 72 K (48.8) (86.2) (52.9) 2 165.7 571.7 83.4 354.2
CHANGE IN CASH
Net Change In Cash (93.1) (310.1) (513.8) (486.1) 1 827.0 2.9 40.5 18.0
FREE CASH FLOW
Free Cash Flow (98.2) (265.2) (518.8) (691.3) (153.1) (273.8) (173.5) (156.7)